Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants

Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants Publisher

Marzbanrad S¹ ; Bahmani S² ; Kazemi A³ ; Taheri HR⁴

Source: Annals of Medicine and Surgery Published:2022

Abstract

Introduction: and Importance: Severe COVID19 patients under anticoagulant therapy are at the risk of developing hematoma. Case presentation: We present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the posterior wall of the abdomen and chest. Clinical discussion: Cases of hematoma with severe COVID19 patients under anticoagulant therapy are reported in several case studies, particularly in geriatric population with the previous history of blood and/or cardiac disorders. Conclusion: These patients should be carefully monitored for hematomas by skilled nurse and practitioner and timely treated and monitored. - © 2022 The Author(s)

Related Docs

View other Related Docs

1. The Use of Remdesivir Among Pregnant Women and Associated Clinical Outcomes in Mother and the Child, Annals of Medicine and Surgery (2022)

2. Prognostic Value of Inflammatory Biomarkers for Predicting the Extent of Lung Involvement and Final Clinical Outcome in Patients With Covid-19, Journal of Research in Medical Sciences (2021)

3. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)

Experts (# of related papers)

View all Related Experts

Hossein Khalili (1)

Pantea Izadi (1)

Style	Citing Format
MLA	Marzbanrad S, et al.. "Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants." Annals of Medicine and Surgery, vol. 78, no. , 2022, pp. -.
APA	Marzbanrad S, Bahmani S, Kazemi A, Taheri HR (2022). Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants. Annals of Medicine and Surgery, 78(), -.
Chicago	Marzbanrad S, Bahmani S, Kazemi A, Taheri HR. "Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants." Annals of Medicine and Surgery 78, no. (2022): -.
Harvard	Marzbanrad S et al. (2022) 'Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants', Annals of Medicine and Surgery, 78(), pp. -.
Vancouver	Marzbanrad S, Bahmani S, Kazemi A, Taheri HR. Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants. Annals of Medicine and Surgery. 2022;78():-.
BibTex	@article{ author = {Marzbanrad S and Bahmani S and Kazemi A and Taheri HR}, title = {Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants}, journal = {Annals of Medicine and Surgery}, volume = {78}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Marzbanrad S AU - Bahmani S AU - Kazemi A AU - Taheri HR TI - Acute Retroperitoneal Hematoma Following Severe Covid-19 and the Use of Anticoagulants JO - Annals of Medicine and Surgery VL - 78 IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Abstract